Navigation Links
Growing Focus on Reducing Drug Development Costs to Drive the Market for Biosimulation, According to a New Trend Report Published by Global Industry Analysts, Inc.
Date:1/7/2014

San Jose, California (PRWEB) January 07, 2014

Follow us on LinkedIn – Growing instances of drug failures in late stage clinical trials is throwing the spotlight on biosimulation. Defined as the use of computers to simulate biological processes, biosimulation is growing in popularity with pharmaceutical companies stepping up investments in this space. Key factors driving adoption of biosimulation tools and solutions among drug developers include growing regulatory, competitive, and budgetary pressures. Broader adoption of pharmacokinetic, and pharmacodynamic modelling in pre-clinical drug discovery is also expected to drive growth in the market.

The trend report titled “Biosimulation” announced by Global Industry Analysts Inc., is a focused research paper which provides cursory insights into the technology, its evolution, applications, future prospects, and corporate initiatives of key companies worldwide. The report provides global market estimates and projections for Biosimulation in US dollars for the years 2012 through 2017. The report also offers coverage on key companies such as Accelrys Inc., Advanced Chemistry Development Inc., Chemical Computing Group Inc., Entelos Inc., GNS Healthcare, In Silico Biosciences Inc., Insilico Biotechnology AG, Molecular Knowledge Systems Inc., Novo Nordisk A/S, Rhenovia Pharma SAS, Simulations Plus Inc., Synergix Ltd., and TheraSim, among others.

For more details about this trend report, please visit http://www.strategyr.com/TrendReport.asp?code=146055.

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

Read the full story at http://www.prweb.com/releases/biosimulation_market/drug_development/prweb11467659.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Growing Research Focus on Single Cell Biology Drives the Market for Single Cell Omics, According to a New Trend Report Published by Global Industry Analysts, Inc.
2. Intrexon Strengthens Leadership in Companys Rapidly Growing Health Sector
3. Embry-Riddle to Launch Forensic Biology Degree to Meet Growing Need for DNA Experts
4. Growing Interest in Regenerative Medicine to Drive the Mesenchymal Stem Cells Market, According to a Soon to Be Released Report by Global Industry Analysts, Inc.
5. Inc. Magazine Unveils Its Annual Exclusive List of America’s Fastest-Growing Private Companies—the Inc.500
6. 5000
7. Envera Files Patent for Low Temperature Growing Bacteria
8. Russias Top 50 Fast-Growing High-Tech Companies
9. New Enterprise Associates Opens Boston Office To Serve Growing Portfolio, Pursue New Investments
10. Workforce Solutions Company Kaztronix is Recognized for the Second Time on Inc. Magazine's List of the 5000 Fastest-Growing Private Companies in America
11. Indigo BioSystems, Inc. Ranks in the 2013 Inc. 500
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... MENLO PARK, Calif. , Feb. 4, 2016 /PRNewswire/ ... "Company"), a biopharmaceutical company focused on the development and commercialization ... at the 18 th Annual BIO CEO & ... a.m. EST in New York, NY . ... will provide an update on the ongoing clinical trial of ...
(Date:2/4/2016)... Feb. 4, 2016 Sinovac Biotech Ltd. ("Sinovac" ... provider of biopharmaceutical products in China ... board of directors received on February 4, 2016 a ... a consortium comprised of PKU V-Ming ( Shanghai ... Ltd., CICC Qianhai Development ( Shenzhen ) ...
(Date:2/3/2016)... , Feb. 3, 2016   ViaCyte, ... with the first pluripotent stem cell-derived islet replacement ... in clinical-stage development, today announced that ViaCyte and ... Companies of Johnson & Johnson, have agreed to ... into ViaCyte.  The agreement provides ViaCyte with an ...
(Date:2/3/2016)... and HOLLISTON, Mass., Feb. 3, 2016 Harvard ... a biotechnology company developing bioengineered organ implants for ... today announced that CEO Jim McGorry , ... Investor Conference on Tuesday, February 9, 2016 ... York City . HART,s presentation will be ...
Breaking Biology Technology:
(Date:1/22/2016)... http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ... "Global Biometrics Market in Retail Sector 2016-2020" ... --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) has announced the ... in Retail Sector 2016-2020" report to ... and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ) has announced ...
(Date:1/18/2016)... , Jan. 18, 2016  Extenua Inc., ... that simplifies the use and access of ubiquitous ... go-to-market partnership with American Cyber.  ... extensive experience leading transformational C4ISR and Cyber initiatives ... integrating the latest proven technology solutions," said ...
(Date:1/11/2016)... Jan. 11, 2016  higi, the leading retail ... retail locations, web and mobile, today announced it ... from existing investors. --> ... to further innovate higi,s health platform – its ... portal – including expanding services and programs to ...
Breaking Biology News(10 mins):